CONSILIUM ACQUISITION -RIGHT (CSLMR)

KYG2365L1279

0.16  +0 (+2.56%)

Fundamental Rating

1

Overall CSLMR gets a fundamental rating of 1 out of 10. We evaluated CSLMR against 0 industry peers in the Unkown industry. CSLMR has a bad profitability rating. Also its financial health evaluation is rather negative. CSLMR has a expensive valuation and it also scores bad on growth.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CSLMR was profitable.
CSLMR had a positive operating cash flow in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 3.11%
ROE 8.85%
ROIC N/A
ROA(3y)1.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CSLMR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for CSLMR has been reduced compared to 1 year ago.
The debt/assets ratio for CSLMR is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.82, we must say that CSLMR is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of CSLMR is 1.19, which is an excellent value as it means it would take CSLMR, only 1.19 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.42 indicates that CSLMR is not too dependend on debt financing.
Although CSLMR does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.19
Altman-Z -0.82
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.54 indicates that CSLMR should not have too much problems paying its short term obligations.
CSLMR has a Quick Ratio of 1.54. This is a normal value and indicates that CSLMR is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.54

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CSLMR have decreased strongly by -83.89% in the last year.
EPS 1Y (TTM)-83.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.02%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.20 indicates a rather cheap valuation of CSLMR.
When comparing the Price/Earnings ratio of CSLMR to the average of the S&P500 Index (27.34), we can say CSLMR is valued rather cheaply.
Industry RankSector Rank
PE 3.2
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 0.5
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CSLMR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONSILIUM ACQUISITION -RIGHT

NASDAQ:CSLMR (1/8/2025, 8:00:00 PM)

0.16

+0 (+2.56%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners298.26%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap979.20K
AnalystsN/A
Price TargetN/A
Short Float %0.04%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.2
Fwd PE N/A
P/S N/A
P/FCF 0.5
P/OCF 0.5
P/B 0.18
P/tB 0.18
EV/EBITDA N/A
EPS(TTM)0.05
EY31.25%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.32
FCFY201.79%
OCF(TTM)0.32
OCFY201.79%
SpS0
BVpS0.91
TBVpS0.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.11%
ROE 8.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.19
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 399.35%
Current Ratio 1.54
Quick Ratio 1.54
Altman-Z -0.82
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y219.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y219.75%
OCF growth 3YN/A
OCF growth 5YN/A